Inovio Pharmaceuticals
INO
$11.59
Share price
1.22%
Change (1 day)
1,425.00%
Change (1 year)
Categories
Inovio Pharmaceuticals (INO) - Total assets
Total assets on the balance sheet as of December 2023 : $0.17 B
According to Inovio Pharmaceuticals's latest financial reports the company's total assets are $0.17 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Inovio Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | -50.95% |
| 2022-12-31 | $0.34 B | -29.72% |
| 2021-12-31 | $0.49 B | -8.12% |
| 2020-12-31 | $0.53 B | 274.97% |
| 2019-12-31 | $0.14 B | 9.79% |
| 2018-12-31 | $0.13 B | -29.98% |
| 2017-12-31 | $0.18 B | 7.79% |
| 2016-12-31 | $0.17 B | -18.77% |
| 2015-12-31 | $0.21 B | 62.26% |
| 2014-12-31 | $0.13 B | 49.27% |
| 2013-12-31 | $88.28 M | 95.59% |
| 2012-12-31 | $45.13 M | -26.13% |
| 2011-12-31 | $61.1 M | 8.99% |
| 2010-12-31 | $56.06 M | -30.46% |
| 2009-12-31 | $80.62 M | 106.81% |
| 2008-12-31 | $38.98 M | -1.98% |
| 2007-12-31 | $39.77 M | 10.64% |
| 2006-12-31 | $35.94 M | 24.05% |
| 2005-12-31 | $28.97 M | 38.31% |
| 2004-12-31 | $20.95 M | 29.1% |
| 2003-12-31 | $16.22 M | 199.47% |
| 2002-12-31 | $5.41 M | -18.31% |
| 2001-12-31 | $6.63 M | |
| 2001-03-31 | $11.48 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 97,915.22% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 55,081.89% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 132,394.69% | 🇺🇸 USA |
 Gilead Sciences GILD | $62.12 B | 36,240.82% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 62,300.92% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 43,838.56% | 🇬🇧 UK |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.62 B | 266.35% | 🇺🇸 USA |